Scott Berger
- Response to Inhibition of Receptor‐Interacting Protein Kinase 1 (RIPK1) in Active Plaque Psoriasis: A Randomized Placebo‐Controlled Study
2020/04/17 by Kathleen Weisel, Scott B. Berger, Scott Berger +10 · 25 citations
Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · Medicine · #Psoriasis: Treatment and Pathogenesis #NF-κB Signaling Pathways #Cytokine Signaling Pathways and Interactions